InsidersTradesSigma
라파스 Stock: price and insider trades · South Korea · DART (FSS)
Track the 라파스 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 라파스 has logged 82 public disclosures. Market capitalisation: €73.5bn. The latest transaction was filed on 2 June 2026 (Purchase). Among the most active insiders: 정도현. The full history is free.
82
Insider Decl.
n/a
Thresholds
€264,094
10 ops.
Buy Volume
n/a
37 ops.
Sell Volume
32Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,777 of 28,065 companies
23.7
score / 100
Value23
Quality24
FCF yld0.9%
Earn yld-5.7%
EV/EBITDA37.6x
ROE-13%
Gross mgn45%
Net mgn-14%
Debt/EBITDA11.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 2 June 2026
Declarations82 total
25 of 82 declarations
About 라파스
The company 라파스 operates in the healthcare and pharmaceutical sector. It is listed on the XKRX market.